Doctor of Philosophy in Pharmacology and Therapeutics (PhD)
Quick Facts
Application
| Deadlines for | ||
|---|---|---|
| Start date | Students with Canadian or US credentials | Students with international credentials |
| September | April 1st | March 1st |
| January | August 1st | July 1st |
| May | December 1st | November 1st |
| July | February 1st | January 1st |
Program contact details
- Wynne Leung, wynne.leung@ubc.ca
Medical Sciences Block C
Room 211 - 2176 Health Sciences Mall
Vancouver
British Columbia, V6T 1Z3
Canada
General Information
The graduate program in Pharmacology was established in 1951, and currently includes programs in cardiovascular pharmacology, neuropharmacology, viral pharmacology, free radical biology, and drug development. Additional training programs exist in therapeutics, evidence-based medicine, and clinical investigation. The pharmacology graduate program has strengths in basic science as well as translational research.
The graduate program in Pharmacology is a component of the newly formed Department of Anesthesiology, Pharmacology & Therapeutics, and formalizes the Department's historical research and academic interactions. Within this new structure, additional research programs reflecting the close association between the disciplines of anesthesiology, pharmacology, and therapeutics are now available. Courses in pharmacology are taught at the undergraduate science, medical, dental, and graduate levels.
The program adheres to an 'apprenticeship' model of graduate training, in which graduate students work in close collaboration with a faculty member who is also their graduate supervisor. The program has strengths in projects covering a wide range of scientific and clinical areas of investigation. The primary aim of our graduate training program is to provide students with the skills necessary to conduct research in pharmacology and therapeutics that can be published in first-rate journals. Thus, an important factor in an applicant's admissibility is a matching of research and professional interests of the student and a faculty member within the program.
The Department has facilities available for original investigations in cellular, biochemical, viral, autonomic, cardiovascular, clinical, and neuropharmacology.
Tuition / Program costs
| Fees | Canadian Citizen / Permanent Resident / Refugee / Diplomat | International |
|---|---|---|
| Application Fee | $91.80 | $153.00 |
| Tuition * | ||
| Installments per year | 3 | 3 |
| Tuition per installment | $1,449.72 | $2,546.90 |
| Tuition per year | $4,349.16 | $7,640.70 |
| Int. Tuition Award (ITA) per year (if eligible) | $3,200.00 (-) | |
| Other Fees and Costs | ||
| Student Fees (yearly) | $709.00 (approx.) | |
| Costs of living (yearly) | $16,763.00 (approx.) | |
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
Recent Doctoral Citations
- Dr. Bo Yang: "Dr. Yang's research indicates that the equilibrium potential of GABA, a major neurotransmitter in brain, is regulated by different receptors, proteins and neuronal activity. Changes in the equilibrium potential, observed in this study, have significant implications for regulating brain activity and implications for promoting health and reducing disease." (November 2011)
- Dr. Koen Raedschelders: "Dr. Raedschelders investigated the influence of general anesthetics on oxidative injury during heart surgery. This research provides insight into the damage that the heart sustains during the course of these operations." (May 2011)
- Dr. Marco Antonio Isidro Perez Garcia: "Dr. Perez systematically reviewed randomized trials of anti-hypertensive drugs that were administered shortly after an acute cardiovascular event. He found a previously unrecognized mortality reduction associated with nitrate administration after acute myocardial infarction. His research emphasizes the value of checking all-cause mortality the timing of drug administrations." (November 2010)
- Dr. Harley Syyong: "Dr. Syyong showed that intracellular calcium oscillations dynamically control regional blood flow in the brains of the young and healthy. He discovered that loss of these calcium oscillations and their compensation by slower enzyme-based signaling is associated with vascular disease and possibly aging, thus explaining loss of function." (November 2010)
- Dr. Haroutioun Krikor Tossonian: "Dr. Tossonian evaluated the treatment of HIV infection in injection drug users on the Downtown East side of Vancouver showing that treatment of HIV infection in this vulnerable population can be remarkably successful if implemented within a directly observed therapy program." (November 2009)
